Distinct mesenchymal cell states mediate prostate cancer progression.

Saved in:
Bibliographic Details
Title: Distinct mesenchymal cell states mediate prostate cancer progression.
Authors: Pakula H; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY 10021, USA., Omar M; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY 10021, USA., Carelli R; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY 10021, USA., Pederzoli F; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY 10021, USA., Fanelli GN; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY 10021, USA.; Department of Laboratory Medicine, Pisa University Hospital, Division of Pathology, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa 56126, Italy., Pannellini T; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY 10021, USA., Van Emmenis L; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY 10021, USA., Rodrigues S; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY 10021, USA., Fidalgo-Ribeiro C; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY 10021, USA., Nuzzo PV; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY 10021, USA., Brady NJ; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY 10021, USA., Jere M; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY 10021, USA., Unkenholz C; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY 10021, USA., Alexanderani MK; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY 10021, USA., Khani F; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY 10021, USA.; Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine, Belfer Research Building, 413 East 69th Street, New York, NY 10021, USA.; Department of Urology, Weill Cornell Medicine, New York, NY 10021, USA., de Almeida FN; Departments of Molecular Pharmacology and Therapeutics, Urology, Medicine, Pathology & Cell Biology and Systems Biology, Herbert Irving Comprehensive Cancer Center, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, NY 10032, USA., Abate-Shen C; Departments of Molecular Pharmacology and Therapeutics, Urology, Medicine, Pathology & Cell Biology and Systems Biology, Herbert Irving Comprehensive Cancer Center, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, NY 10032, USA., Greenblatt MB; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY 10021, USA., Rickman DS; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY 10021, USA., Barbieri CE; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY 10021, USA.; Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine, Belfer Research Building, 413 East 69th Street, New York, NY 10021, USA.; Department of Urology, Weill Cornell Medicine, New York, NY 10021, USA., Robinson BD; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY 10021, USA.; Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine, Belfer Research Building, 413 East 69th Street, New York, NY 10021, USA.; Department of Urology, Weill Cornell Medicine, New York, NY 10021, USA., Marchionni L; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY 10021, USA., Loda M; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY 10021, USA.; Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine, Belfer Research Building, 413 East 69th Street, New York, NY 10021, USA.; Department of Oncologic Pathology, Dana-Farber Cancer Institute and Harvard Medical School, 450 Brookline Ave, Boston, MA, 02215, USA.
Source: BioRxiv : the preprint server for biology [bioRxiv] 2023 Apr 01. Date of Electronic Publication: 2023 Apr 01.
Publication Type: Preprint; Journal Article
Journal Info: Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet ISSN: 2692-8205 (Electronic) Linking ISSN: 26928205 NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2692-8205
DOI:10.1101/2023.03.29.534769